Cyberknife delivers high levels of targeted radiation through the use of a robotic arm and multiple laser beams, allowing for more targeted treatment by oncologists.
However, at a cost of £2 million per machine, some experts believe the treatment will not be available on the NHS, the Telegraph reports.
But a spokesperson for Cancer Research UK said Cyberknife needs more research in controlled clinical trials to determine whether it is more effective than treatments already in use.
She said early results on some cancers look promising, but there has not yet been a control study.
'And at this stage, we don't know very much about the side effects of this treatment – either in the short or long-term – so we need more research to find out,' the spokesperson added.
However, at a cost of £2 million per machine, some experts believe the treatment will not be available on the NHS, the Telegraph reports.
But a spokesperson for Cancer Research UK said Cyberknife needs more research in controlled clinical trials to determine whether it is more effective than treatments already in use.
She said early results on some cancers look promising, but there has not yet been a control study.
'And at this stage, we don't know very much about the side effects of this treatment – either in the short or long-term – so we need more research to find out,' the spokesperson added.
0 comments:
Post a Comment